chr8-80487156-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001105539.3(ZBTB10):āc.346G>Cā(p.Ala116Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000286 in 1,518,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00013 ( 0 hom., cov: 32)
Exomes š: 0.00030 ( 0 hom. )
Consequence
ZBTB10
NM_001105539.3 missense
NM_001105539.3 missense
Scores
2
1
16
Clinical Significance
Conservation
PhyloP100: 3.86
Genes affected
ZBTB10 (HGNC:30953): (zinc finger and BTB domain containing 10) Predicted to enable RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12227857).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZBTB10 | NM_001105539.3 | c.346G>C | p.Ala116Pro | missense_variant | 1/6 | ENST00000455036.8 | NP_001099009.1 | |
ZBTB10 | NM_023929.5 | c.346G>C | p.Ala116Pro | missense_variant | 1/7 | NP_076418.3 | ||
ZBTB10 | NM_001277145.2 | c.96+1277G>C | intron_variant | NP_001264074.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZBTB10 | ENST00000455036.8 | c.346G>C | p.Ala116Pro | missense_variant | 1/6 | 2 | NM_001105539.3 | ENSP00000412036.3 | ||
ZBTB10 | ENST00000430430.5 | c.346G>C | p.Ala116Pro | missense_variant | 2/7 | 5 | ENSP00000387462.1 | |||
ZBTB10 | ENST00000426744.5 | c.346G>C | p.Ala116Pro | missense_variant | 1/7 | 5 | ENSP00000416134.2 | |||
ZBTB10 | ENST00000379091.8 | c.96+1277G>C | intron_variant | 2 | ENSP00000368384.4 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151854Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
19
AN:
151854
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000686 AC: 8AN: 116662Hom.: 0 AF XY: 0.0000468 AC XY: 3AN XY: 64140
GnomAD3 exomes
AF:
AC:
8
AN:
116662
Hom.:
AF XY:
AC XY:
3
AN XY:
64140
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000304 AC: 416AN: 1366870Hom.: 0 Cov.: 34 AF XY: 0.000303 AC XY: 204AN XY: 672886
GnomAD4 exome
AF:
AC:
416
AN:
1366870
Hom.:
Cov.:
34
AF XY:
AC XY:
204
AN XY:
672886
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 19AN: 151968Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74312
GnomAD4 genome
AF:
AC:
19
AN:
151968
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.346G>C (p.A116P) alteration is located in exon 1 (coding exon 1) of the ZBTB10 gene. This alteration results from a G to C substitution at nucleotide position 346, causing the alanine (A) at amino acid position 116 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
P;P;P
Vest4
MutPred
Gain of loop (P = 0.0045);Gain of loop (P = 0.0045);Gain of loop (P = 0.0045);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at